Pharmaceutical industry marketing of opioids and related payments to physicians are associated with increased subsequent opioid prescribing, according to a research letter published in JAMA Internal Medicine.
“Pharmaceutical industry marketing to physicians is widespread, but it is unclear whether marketing of opioids influences prescribing,” Scott E. Hadland, MD, MPH, MS, from Grayken Center for Addiction, Boston Medical Center, and colleagues wrote.
Hadland and colleagues investigated how pharmaceutical industry marketing of opioids to physicians affects opioid prescribing.
The
Uncategorized